PC 2 mod 2.2 lec 14-16

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/120

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 12:25 AM on 8/15/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

121 Terms

1
New cards

fosfomycin is a SMALL/LARGE molecule that easily forms _____ and has HIGH/LOW BA with use limited to ______

- small

- salts

- low

- UTI

2
New cards

______ is a small molecule that easily forms salts and has low BA so limits use to UTI

fosfomycin

3
New cards

fosfomycin MOA

--> enters cell through 2 active transport systems ______ and _____

--> once in, it reversible blocks _____

--> acts as an analog of ______ and inhibits initial ____ synthesis step triggered by _____

--> blocks production of _____

- GLpT

- UhpT

- bacterial cell wall synthesis

- phosphoenolpyruvate

- peptidoglycan

- MurA

- NAM

4
New cards

______ has MOA of entering cell through 2 active transport systems, GLpT and UhpT to reversibly blood cell wall synthesis by acting as an analog of phsophoenolpyruvate inhibiting initial peptidoglycan synthesis step triggered by MurA and blocking NAM

fosfomycin

5
New cards

is Vd of fosfomycin high or low?

low

6
New cards

fosfomycin is eliminated by _____ route and 93% ends up in ______

- renal

- urine

7
New cards

does fosfomycin have good protein binding?

no

8
New cards

is fosfomycin oral or IV? what is the agent called?

oral

fosfomycin tromethamine (dissociates in blood)

9
New cards

which of the following gram + does fosfomycin have activity against?

a. streptococcus spp.

b. s. pneumoniae

c. viridans strep

d. MSSA/MSSE

e. MRSA/MRSE

f. E. faecalis

g. E. faecium

d. MSSA/MSSE

e. MRSA/MRSE

f. E. faecalis

g. E. faecium

10
New cards

which of the following gram- does fosfomycin have activity against? (pt1)

a. neisseria spp.

b. H. influenzae

c. M. catarrhalis

d. e. coli

e. klebsiella

f. p. mirabilis

a. neisseria spp.

d. e. coli

e. klebsiella

f. p. mirabilis

MORE COMMON FOR UTI

11
New cards

which of the following gram- does fosfomycin have activity against? (pt2)

a. morganella spp

b. enterobacter spp

c. citrobacter spp

d. serratia spp

e. p. paeruginosa

f. acinetobacter

b. enterobacter spp

c. citrobacter spp

d. serratia spp

e. p. paeruginosa

NOT AS COMMON

12
New cards

fosfomycin has misc activity against... (5)

- salmonella

- shigella

- listeria

- aerococcus

- h pylori

13
New cards

mechanisms of resistance of fosfomycin...

--> altered bindining due to mutations in _____

--> overexpression of ______ circumventing activity of fosfomycin

--> mutations in ______

--> modifying ______

- murA

- enolypyruvyl transferase

- transport system

- enzymes

14
New cards

fosfomycin has interactions with drugs that stimulate ______, as they decrease _____

- motility

- absorption

15
New cards

3 places in therapy for fosfomycin

- uncomplicated acute cystitis

- complicated cystitis

- prophylaxis

16
New cards

fosfomycin for uncomplicated acute cystitis is administered as ___gm dose ___x and the preparation is _____ that must be ______

3g one time

- power

- mixed with 4 oz water

17
New cards

fosfomycin for complicated cystitis is giving ___gm q___h for up to ___ doses

- 3gm

- q48h

- 3 doses

18
New cards

dose of fosfomycin for prophylaxis of recurrent UTI is give ___gm every ___ days

3gm

10 days

19
New cards

recurrent UTI is defined as at least ____ episodes of COMPLICATED/UNCOMPLICATED infection document by cultures within the past 12 months

- 3 episodes

- uncomplicated

20
New cards

con with fosfomycin is...

cost

21
New cards

MOA of nitrofurantoin

--> nitrofurantoin is activated by ______ to reactive intermediates

--> these intermediates damage ______, ____ and other macromolecules involved in ______ and _______

- bacterial flavoproteins

- ribosomal proteins

- DNA

- metabolism

- cell wall synthesis

22
New cards

______ has MOA of being activated by bacterial flavoproteins to become reactive intermediate

nitrofurantoin

23
New cards

bacteria reduce nitrofurantoin more _______ than mammilian cells, so it is selective for that

rapidly

24
New cards

PK of nitrofurantoin

--> HIGH/LOW BA

--> SHORT/LONG T1/2

--> elimination?

--> conc in urine? serum?

- high

- short

- renal and biliary

- high in urine, low in serum

25
New cards

elimination of nitrofuranoin through kidney leave it ______

unchanged

26
New cards

ACIDIC/ALKALINE urine may reduce antimicrobial activity of nitrofuranoin

alkaline

27
New cards

clinical response of nitrofurantoin is based on _______, so impaired ______ limits use

- urine conc

- renal function

28
New cards

does nitrofurantoin enter tissues well?

no

29
New cards

3 drug of nitrfurantoin class

- macrobid

- macrodantin

- furadantin

30
New cards

should you take nitrofurantoin for pyelonephritis?

no

31
New cards

should you take nitrofurantoin with food?

yes

32
New cards

does nitrofurantoin need renal adjustment? if so, at what CrCL?

yes,

33
New cards

which of the following gram + does nitrofurantoin have activity against?

a. streptococcus spp.

b. s. pneumoniae

c. viridans strep

d. MSSA/MSSE

e. MRSA/MRSE

f. E. faecalis

g. E. faecium

d. MSSA/MSSE

e. MRSA/MRSE

f. E. faecalis

g. E. faecium

34
New cards

which of the following gram- does nitrofurantoin have activity against? (pt1)

a. neisseria spp.

b. H. influenzae

c. M. catarrhalis

d. e. coli

e. klebsiella

f. p. mirabilis

d. e. coli

e. klebsiella

CAUSE UTI

35
New cards

which of the following gram- do nitrofurantoin have activity against? (pt2)

a. morganella spp

b. enterobacter spp

c. citrobacter spp

d. serratia spp

e. p. aeruginosa

f. acinetobacter

b. enterobacter

c. citrobacter

e. p aeruginosa

36
New cards

hemolytic anemia from nitrofurantoin is more common in patients with _____ deficiency

G6PD

37
New cards

nitrofurantoin can cause rare events, like ______ if used long term or _____ in patients with G6PD deficiency

- pulmonary toxicity

- hemolytic anemia

38
New cards

______ can cause rare events, like pulmonary toxicity if used long term or hemolytic anemia in patients with G6PD deficiency

nitrofurantoin

39
New cards

nitrofurantoin is contraindicated in ______ and ______

- pregnancy

- neonate

(hemolytic anemia)

40
New cards

nitrofurantoin can cause color of urine to be...

brown

41
New cards

nitrofurantoin has drug interactions with ______ and ______

- magnesium based antacids

- probenecid

42
New cards

probenecid INCREASES/DECREASES nitrofurantoin conc

increases

43
New cards

magnesium based antacid INCREASE/DECREASE nitrofurantoin absorption

decrease

44
New cards

nitrofurantoin can cause false positive ______ lab test

glucosuria

45
New cards

nitrofurantoin is ONLY indicated for...

cystitis

46
New cards

treatment duration for nitrofurantoin treating cystitis is typically ____ days for uncomplicated disease

5 days

47
New cards

nitrofurantoin prophylaxis dose for recurrent UTI is ____ mg po ____

50-100mg po daily

48
New cards

can you use nitrofurantoin long for prophylaxis?

no, dangerous

49
New cards

polymyxins are CATION/ANION and HYDROPHILIC/HYDROPHOBIC

cation

amphiphilic

50
New cards

polymyxins have hydrophilic _______ and hydrophobic _______

- peptide ring

- tail

51
New cards

_____ are positively charged amino groups found on polymyxins

L-dab

52
New cards

L-dabs are _____ charged _____ groups on ______

- positively charged

- amino

- polymyxins

53
New cards

MOA of polymyxins

--> _____ align with _____, which is POSITIVE/NEGATIVE charge of gram POSITIVE/NEGATIVE

--> _____ interacts with bacterial cell membrane

--> this causes increase in _____ of cell wall

- L-dab

- LPS

- negatively

- negative

- hydrophobic tail

- permeability

54
New cards

______ has MOA of L-dab (positive amino groups), lining up and binding to LPS causing hydrophobic tail to increase permeability of cell wall

polymyxins

55
New cards

two types of polymyxins

- colistin

- polymyxin B

56
New cards

polymyxin PK

--> HIGH/LOW BA

low

57
New cards

are polymyxins renally eliminated?

colistin (CMS) is

polymyxin b is not

58
New cards

CMS IS/IS NOT renally eliminated

colistin IS/IS NOT renally eliminated

polymyxin b IS/IS NOT renally eliminated

- is

- is not

- is not

59
New cards

which is more protein bound, colistin or polymyxin B?

polymyxin B

60
New cards

colistin has GOOD/POOR penetration into lung, pericardium and CSF?

poor

61
New cards

______ colistin optimizes lung exposure

inhaled

62
New cards

are urine concentrations of colistin HIGH or LOW?

high

63
New cards

urine conc. of colistin are high due to conversion of _____ to _____ in _____

- colistimethate

- colistin

- kidney

64
New cards

polymyxins are CONCENTRATION/TIME dependent?

concentration

65
New cards

colistin is administered as...

inactive prodrug, colistimethate sodium

66
New cards

why is colistin administered as prodrug?

fewer injection site reactions

67
New cards

in patients with good renal function, colistimethate sodium (CMS) clearance is SLOWER/FASTER than conversion to colistin, leading to LOW/HIGH serum conc.

- faster

- low

(20-25%)

68
New cards

variables effect colistin conc. are ____ variability and variability in _____

- batch to batch

- renal function

69
New cards

does polymyxin B or colistin have improved serum conc?

polymyxin B

70
New cards

polymyxin B is _____ in kidney, resulting in LOW/HIGH urinary conc. which is not good for _____

- reabsorbed

- low

- UTI

71
New cards

can colistin be used for systemic infection? can polymyxin?

- no

- yes

72
New cards

do polymyxins have activity against gram-? gram+?

yes

no

73
New cards

which gram+ bacteria do polymyxins have activity against?

none

74
New cards

which of the following gram- do polymyxins have activity against? (pt1)

a. neisseria spp.

b. H. influenzae

c. M. catarrhalis

d. e. coli

e. klebsiella

f. p. mirabilis

b. H. influenzae

c. M. catarrhalis

d. e. coli

e. klebsiella

75
New cards

which of the following gram- do polymyxins have activity against? (pt2)

a. morganella spp

b. enterobacter spp

c. citrobacter spp

d. serratia spp

e. p. aeruginosa

f. acinetobacter

b. enterobacter spp

c. citrobacter spp

e. p. aeruginosa

f. acinetobacter

76
New cards

is colistin adjusted renally?

yes

77
New cards

mechanisms of resistance of polymyxins

--> alterations of ______

--> increased production of _____

--> ______

--> increasing levels of _____ by replacing ____ to stabilize the outer membrane

- LPS

- capsule polysaccharide

- efflux proteins

- H1 outer membrane protein

- Mg

78
New cards

resistance of polymyxin by alteration of LPS is done by INCREASING/DECREASING net charge, limiting binding

increasing

79
New cards

intrinsic resistance of polymyxins is driven by...

alteration of LPS

80
New cards

increased production of capsule polysaccharide reduce polymyxins by limiting their interaction with _______

LPS

81
New cards

increased levels of H1 mechanism of resistance to polymyxins works by replacing _____ in LPS to stabilize outer membrane

Mg

82
New cards

dosing strategy for colistin includes ______ dose, ______ dose, and ______ adjustment

- loading

- maintenance

- renal

83
New cards

dosing weight used for polymyxin B is...

total body weight (NOT IDEAL)

84
New cards

dosing strategy for polymyxin B is use of _____ weight, _____ dose, _____ dose and NO renal adjustment

- total body weight

- loading

- maintenance

85
New cards

2 adverse effects that can occur with polymyxins

- nephrotoxicity

- neuromuscular blockade

86
New cards

onset of nephrotoxicity from polymyxins would be within _____ weeks and it is dependent on ______

- 1 week

- dose

87
New cards

nephrotoxicity of polymyxin is due to mechanism similar to MOA, where polymyxins increase ________ cell membrane permeability resulting in cell ______ and ______

- tubular

- swelling

- lysis

88
New cards

neuromuscular blockade caused by polymyxin is ____ dependent and REVERSIBLE/IRREVERSIBLE and happens due to blocking release of ______

- dose

- reversible

- ACh

89
New cards

is polymyxin or colistin considered more reliable?

polymyxin

90
New cards

______ is preferred polymyxin for systemic and invasive infections

______ is preferred polymysin for lower UTI infections

- polymyxin B

- colistin

91
New cards

polymyxins are ______-line of therapy for ______ and are used in ______ therapy

- last line

- extensively drug resistant (XDR) gram- bacilli

- combination

92
New cards

_______ is last line therapy for XDR gram- bacilli

polymyxins

93
New cards

which of the following have high BA?

a. fosfomycin

b. nitrofurantoin

c. polymyxin

b. nitrofurantoin

94
New cards

which of the following have low BA?

a. fosfomycin

b. nitrofurantoin

c. polymyxin

a. fosfomycin

c. polymyxin

95
New cards

forsfomycin and nitrofurantoin have same coverage of GRAM +/GRAM - which is... (4)

- gram +

- MSSA

- MRSA

- both enterococcus

96
New cards

is polymyxin B good for UTIs?

no, reabsorbing kidney

97
New cards

which drug uses TBW for dosing?

polymyxin B

98
New cards

unique in dosing of polymyxin B and colistin is use of...

loading dose and maintenance dose

99
New cards

which of the following covers neisseria, p.miribalis, and serratia?

a. fosfomycin

b. nitrofurantoin

c. polymyxin

a. fosfomycin

100
New cards

fosfomycin covers _______, _______ and _______ gram- that nitrofurantoin and polymyxins don't cover

- neiserria

- p. miribalis

- serration